Anaridex 1 mg Tablets

Anastrozole belongs to a class of medications known as aromatase inhibitors, which work by blocking the enzyme aromatase, responsible for converting other hormones into estrogen in the body. Since many breast cancers rely on estrogen to grow, reducing its production helps slow or stop the progression of hormone receptor-positive breast cancer. It is commonly used in postmenopausal women with early-stage or advanced breast cancer, either as an initial treatment or following surgery, as part of a comprehensive treatment strategy to help reduce the risk of cancer recurrence. Anastrozole is generally well suited for long-term use, often continued for several years as part of adjuvant therapy following primary breast cancer treatment. It is taken orally, usually once daily, offering a convenient and consistent dosing schedule for extended hormone therapy. Regular monitoring, including bone density checks and periodic follow-up imaging, is an important part of treatment to help support overall health and track the body's response over time. Many patients experience meaningful reduction in cancer recurrence risk and improved long-term outcomes with consistent use of Anastrozole. Ongoing follow-up with an oncologist helps ensure the treatment remains appropriate and effective throughout the course of therapy. As with all hormone therapies for cancer treatment, Anastrozole should be used under the close supervision of a healthcare provider experienced in breast cancer care.